Effectiveness of RSV Prevention Strategies in US Infants: 2024-2025.
Nirsevimab and maternal RSV vaccination were effective against RSV-associated ED encounters and hospitalization among infants in their first RSV season, and monitoring infant RSV immunization effectiveness remains important.